Granules India unit completes USFDA inspection at Hyderabad facility with 5 observations

The inspection was conducted from December 15 to December 19, 2025, and concluded with five observations related to procedural requirements. The company said none of the observations are associated with data integrity or product safety. Shares of Granules India Ltd ended at ₹583.30, up by ₹2.90, or 0.50%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *